Combination of Olanzapine and Samidorphan Has No Clinically Significant Effect on the Pharmacokinetics of Lithium or Valproate

BACKGROUND AND OBJECTIVE: Olanzapine is an atypical antipsychotic indicated for the treatment of schizophrenia and, either as monotherapy or as an adjunct to lithium or valproate, for bipolar I disorder. Multiple daily doses of olanzapine do not affect the pharmacokinetics of lithium or valproate; t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Lei, Yagoda, Sergey, Yao, Baiyun, Graham, Christine, von Moltke, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962313/
https://www.ncbi.nlm.nih.gov/pubmed/31584140
http://dx.doi.org/10.1007/s40261-019-00860-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962313/
https://www.ncbi.nlm.nih.gov/pubmed/31584140
http://dx.doi.org/10.1007/s40261-019-00860-y

Ejemplares similares